Consequently, inadequate expression of SET8 due to single nucleotide polymorphism (SNP) in the miR-502 binding site has been linked to the susceptibility and outcome of different malignancies, such as breast cancer and other [25, 26, 27]. The gene discussed is KMT5A; the disease is breast carcinoma.